Christine Anne Holmstedt, DO

Dorothy Tyson, MSN, FNP is a highly experienced Family Nurse Practitioner specializing in Neurosurgery in Charleston, SC. With a strong educational background from Saint Joseph's College of Maine, College of Nursing, Dorothy provides exceptional care to her patients, offering a wide range of medical services and accepting various insurance plans. Located at MUSC Health Rutledge Tower, Dorothy Tyson, MSN, FNP is dedicated to delivering comprehensive healthcare, ensuring the well-being of her patients. With a focus on personalized treatment and a deep understanding of her field, she is committed to providing the highest quality of care in a compassionate manner.Generated from the website

This provider is no longer seeing patients at MUSC Health.

Patrick Flume is a Distinguished Professor of Medicine and Pediatrics at the Medical University of South Carolina. He serves as the Powers-Huggins Endowed Chair for Cystic Fibrosis and oversees a large Cystic Fibrosis (CF) Center, including the largest adult CF program in South Carolina. He also leads large clinical programs dedicated to patients with bronchiectasis and non-tuberculous mycobacterial (NTM) infections. He is recognized by the national and international CF community having served on the CF Foundation Center Committee, the Adult Care Consensus Committee, and the Advisory Task Force on Adult Issues, the Professional Education Committee, the European CF Society’s Best Practices committee, and as founding co-chair of the CF Foundation’s Pulmonary Practice Guidelines Committee. He co-led the International Working Group on Antimicrobial Resistance in Cystic Fibrosis. He is the Editor-in-Chief for the Journal of Cystic Fibrosis. He serves as Associate Vice President for Clinical Research at MUSC, leads a very busy clinical research program for CF, bronchiectasis, and NTM, and is co-principal investigator for the South Carolina Clinical & Translational Research Institute. Many of these studies are related to new drug and therapy development for patients, but he also has an interest in determining optimal management of CF pulmonary exacerbations and is the co-PI in the STOP trials, aimed at identifying optimal treatments for exacerbations.